Your browser doesn't support javascript.
loading
Improving pharmacological targeting of AKT in melanoma.
Kuzu, Omer F; Gowda, Raghavendra; Sharma, Arati; Noory, Mohammad A; Dinavahi, Saketh S; Kardos, Gregory; Drabick, Joseph J; Robertson, Gavin P.
Afiliação
  • Kuzu OF; Department of Pharmacology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA.
  • Gowda R; Department of Pharmacology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA; The Melanoma Center, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA.
  • Sharma A; Department of Pharmacology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA.
  • Noory MA; Department of Pharmacology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA.
  • Dinavahi SS; Department of Pharmacology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA.
  • Kardos G; Department of Pharmacology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA.
  • Drabick JJ; Department of Medicine, Division of Hematology-Oncology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA; The Melanoma Center, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA.
  • Robertson GP; Department of Pharmacology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA; Department of Pathology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA; Department of Dermatology, The Pennsylvania State University, College of Medicine, Hers
Cancer Lett ; 404: 29-36, 2017 09 28.
Article em En | MEDLINE | ID: mdl-28705772
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores Enzimáticos / Proteínas Proto-Oncogênicas c-akt / Terapia de Alvo Molecular / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores Enzimáticos / Proteínas Proto-Oncogênicas c-akt / Terapia de Alvo Molecular / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article